Nifty 50
- Apollo Hospitals₹9,200462.00 (5.29%)
- Titan Company₹4,620-80.00 (-1.70%)
- Axis Bank₹1,44665.20 (4.72%)
- Tata Steel₹178-2.89 (-1.60%)
- Max Healthcare₹1,08140.35 (3.88%)
- NTPC₹321.50-3.50 (-1.08%)
- Maruti Suzuki₹14,011422.00 (3.11%)
- Hindustan Unilever₹2,052.50-21.70 (-1.05%)
- UltraTech Cement₹12,939379.00 (3.02%)
- Jio Financial ₹224.97-1.83 (-0.81%)
- HDFC Bank₹84624.20 (2.94%)
- Sun Pharmaceutical₹1,884.90-15.10 (-0.79%)
- Bajaj Finance₹1,12229.15 (2.67%)
- Eternal₹364-2.85 (-0.78%)
- Kotak Mahindra Bank₹515.8012.80 (2.54%)
- Dr. Reddy's Labs₹1,390.20-10.70 (-0.76%)
- Hindalco Industries₹929.5019.50 (2.14%)
- ITC₹299.10-1.90 (-0.63%)
- InterGlobe Aviation₹5,587.60112.60 (2.06%)
- Bharat Electronics₹402-2.20 (-0.54%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Algo Strategy
- Markets
Stocks
F&O
Mutual Funds
- More
Lupin Gets USFDA Nod for Generic Tablets To Treat Excessive Daytime Sleepiness
Authored By PTI | Last Modified: Aug 17, 2026 02:00 PM IST

Open Free Demat Account
New Delhi: Pharma major Lupin Ltd on Monday said it has received final approval from the US health regulator for the generic version of Pitolisant tablets indicated to treat excessive daytime sleepiness.
The approval by the US Food and Drug Administration (USFDA) is for the abbreviated new drug application for Pitolisant Tablets of strengths 4.45 mg and 17.8 mg, Lupin Ltd said in a regulatory filing.
The USFDA has approved Lupin’s Pitolisant tablets, 4.45 mg and 17.8 mg, as bioequivalent to Wakix, the company said.
Wakix is a prescription medicine used to treat excessive daytime sleepiness (EDS) of Harmony Biosciences.
(Disclaimer: Except for the headline, this article has not been edited by HDFC Sky editorial team and is auto-generated from PTI feed.)
Disclaimer
If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.
Please Note: The information shared is intended solely for informational purposes and does not make any investment recommendations
Disclaimer
The information shared here is intended solely for informational and educational purposes and does not constitute investment recommendations. While we practice strict due diligence in curating daily market data, readers must perform independent research before trading. To flag any real-time data discrepancies or content concerns, please write to us at content@hdfcsec.com.
More LUPIN News
Open Free Demat Account
₹2,014
By signing up I certify terms, conditions & privacy policy
Join Us
Add as preferred source on Google


















